|
Market Closed -
Other stock markets
|
After hours 12:21:25 am | |||
| 337.50 EUR | -1.17% |
|
338.00 | +0.15% |
| 29/07 | Virbac, without the alibi |  |
| 21/07 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Veterinary Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 329.38Cr | |||||
| 3.19TCr | |||||
| 1.32TCr | |||||
| 381.62Cr | |||||
| 191.21Cr | |||||
| 189.37Cr | - | - |
- Stock Market
- Stocks
- VIRP Stock
- Charts Virbac
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
